GLP-1 Weight Loss Trend

Join host Julia Cartwright as she unpacks the GLP-1 weight loss revolution, exploring the science behind those weekly injections everyone's talking about and asking the hard questions about long-term dependency that others avoid. With straight talk, humor, and zero judgment, Julia breaks down the real numbers and cultural impact. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Host Julia Cartwright examines whether GLP-1 medications like Ozempic represent a genuine solution or temporary fix for weight loss. The episode covers clinical research, long-term sustainability challenges, muscle loss concerns, and the reality that many patients may need lifelong treatment. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Julia Cartwright explores how Ozempic transformed from a diabetes medication into a cultural phenomenon, examining "Ozempic face," stigma, body positivity tensions, and economic ripple effects. She discusses why 12.4% of Americans now use GLP-1s, the ethical questions around supply shortages, and what this $105 billion industry reveals about our relationship with weight, morality, and systemic healthcare challenges. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Join host Julia Cartwright as she examines the GLP-1 weight loss phenomenon gripping America. Prescriptions surged 587%, 41 million Americans have tried these drugs, and obesity rates dropped nationally for the first time in a decade. But half of users quit within a year. We explore the dramatic numbers and what happens when the injections stop. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.